Evaluation of the effects of 18 non-synonymous single-nucleotide polymorphisms of CYP450 2C19 on in vitro drug inhibition potential by a fluorescence-based high-throughput assay

By Wang Huijuan   Kim Raymond A.   Sun Dongxu   Gao Yiwen   Wang Hao   Zhu Juanli   Chen Chao  

Xenobiotica, Vol. 41, Iss. 9, 2011-09 ,pp. : 826-835

Informa Healthcare

Access to resources Recommend Favorite

High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes

By Yamamoto T.   Suzuki A.   Kohno Y.  

Xenobiotica, Vol. 33, Iss. 8, 2003-08 ,pp. : 823-839

Informa Healthcare

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite

Synthesis of Hydroxy Derivatives of Highly Potent Non-steroidal CYP 17 Inhibitors as Potential Metabolites and Evaluation of their Activity by a Non Cellular Assay using Recombinant Human Enzyme

By Hutschenreuter Tilman U.   Ehmer Peter B.   Hartmann Rolf W.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 19, Iss. 1, 2004-02 ,pp. : 17-32

Informa Healthcare

Access to resources Recommend Favorite

An Automated High-Throughput Sample Preparation Protocol for LC-MS/MS Analysis of Glycopeptides

By  

Current Proteomics, Vol. 13, Iss. 1, 2016-03 ,pp. : 55-60

Bentham Science Publishers

Access to resources Recommend Favorite